Neurotrophic keratitis (NK) is challenging to diagnose and manage, necessitating clinicians to proactively screen patients for this potentially devastating condition. The clinical case presented here illustrates key challenges and considerations associated with the management and treatment of a patient with NK.
Special Collections
Clinical Case Challenge
Anti-vascular endothelial growth factor agents are an appropriate first-line treatment for neovascular age-related macular degeneration, but aflibercept and ranibizumab do not appear to yield significantly different visual and anatomic outcomes.
